Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
Bin He, Rainer B. Lanz, Warren Fiskus, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 51, pp. 18261-18266
Open Access | Times Cited: 113

Showing 26-50 of 113 citing articles:

FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
Jonathan C. Zhao, Ka-wing Fong, Hongjian Jin, et al.
Oncogene (2016) Vol. 35, Iss. 33, pp. 4335-4344
Open Access | Times Cited: 63
Androgens, oestrogens and endometrium: a fine balance between perfection and pathology
Douglas A Gibson, Ioannis Simitsidellis, Frances Collins, et al.
Journal of Endocrinology (2020) Vol. 246, Iss. 3, pp. R75-R93
Open Access | Times Cited: 57
Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?
Emery H. Bresnick, Mabel M. Jung, Koichi R. Katsumura
Blood Advances (2020) Vol. 4, Iss. 18, pp. 4584-4592
Open Access | Times Cited: 57
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT
Tao Shen, Wei Wang, Wolong Zhou, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 4
Open Access | Times Cited: 51
A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer
Fionnuala Crowley, Michelle Sterpi, Conor Buckley, et al.
Research and Reports in Urology (2021) Vol. Volume 13, pp. 457-472
Open Access | Times Cited: 49
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer
Rayzel C. Fernandes, John Toubia, Scott L. Townley, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108585-108585
Open Access | Times Cited: 43
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
Thomas P. Burris, Ian Mitchelle S. de Vera, Isabelle Côté, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1233-1318
Open Access | Times Cited: 20
A review of non-classical MAPK family member, MAPK4: A pivotal player in cancer development and therapeutic intervention
Yaping Yan, Tengkun Dai, Mengmeng Guo, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132686-132686
Closed Access | Times Cited: 6
A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13
Zhifei Luo, Suhn K. Rhie, Fides D. Lay, et al.
Cell Reports (2017) Vol. 21, Iss. 6, pp. 1411-1417
Open Access | Times Cited: 60
Emerging data on androgen receptor splice variants in prostate cancer
Subing Cao, Zhan Yang, Yan Dong
Endocrine Related Cancer (2016) Vol. 23, Iss. 12, pp. T199-T210
Open Access | Times Cited: 55
Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer
Zoran Čulig
Journal of Cellular Physiology (2015) Vol. 231, Iss. 2, pp. 270-274
Closed Access | Times Cited: 53
Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer
Christopher Foley, Nicholas Mitsiades
Hormones and Cancer (2016) Vol. 7, Iss. 2, pp. 84-103
Open Access | Times Cited: 51
Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer
Hongjian Jin, Segun Jung, Auditi DebRoy, et al.
Oncotarget (2016) Vol. 7, Iss. 34, pp. 54616-54626
Open Access | Times Cited: 47
Molecular determinants for enzalutamide-induced transcription in prostate cancer
Fuwen Yuan, William Hankey, Dayong Wu, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 19, pp. 10104-10114
Open Access | Times Cited: 46
Androgen Receptor-Mediated Transcription in Prostate Cancer
Doğancan Özturan, Tunç Morova, Nathan A. Lack
Cells (2022) Vol. 11, Iss. 5, pp. 898-898
Open Access | Times Cited: 25
Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohort
Ieva Masliukaitė, Elissavet Ntemou, Elizabeth A. M. Feijen, et al.
Human Reproduction (2023) Vol. 38, Iss. 3, pp. 359-370
Open Access | Times Cited: 15
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth
Daisuke Obinata, Ken‐ichi Takayama, Kyoko Fujiwara, et al.
Oncogene (2016) Vol. 35, Iss. 49, pp. 6350-6358
Open Access | Times Cited: 44
Role of steroid receptor and coregulator mutations in hormone-dependent cancers
Anna C. Groner, Myles Brown
Journal of Clinical Investigation (2017) Vol. 127, Iss. 4, pp. 1126-1135
Open Access | Times Cited: 44
Tissue control of androgen action: The ups and downs of androgen receptor expression
Irene Hunter, C. R. M. Hay, Bianca Eßwein, et al.
Molecular and Cellular Endocrinology (2017) Vol. 465, pp. 27-35
Open Access | Times Cited: 44
Cell cycle-coupled expansion of AR activity promotes cancer progression
Christopher McNair, Alfonso Urbanucci, Clay E.S. Comstock, et al.
Oncogene (2016) Vol. 36, Iss. 12, pp. 1655-1668
Open Access | Times Cited: 40
Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer
Nicholas Mitsiades, Salma Kaochar
Endocrine Related Cancer (2021) Vol. 28, Iss. 8, pp. T19-T38
Open Access | Times Cited: 29
GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects
Lili Kotmayer, Damià Romero–Moya, Oskar Marín-Béjar, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 482-495
Open Access | Times Cited: 20
TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer
Ramesh Singh, Huan Meng, Tao Shen, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 20
Open Access | Times Cited: 12
CRISPR screening identifies regulators of enhancer-mediated androgen receptor transcription in advanced prostate cancer
Rachel R. Xiang, Shin-Ai Lee, C Tyndall, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115312-115312
Open Access
Androgen receptor–regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancer
Yongyong Yang, Ting-You Wang, Qianru Li, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access

Scroll to top